Nicola Palladino
Gubbio, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
COVID-19 in people with Cystic Fibrosis beyond the pre-omicron era: a prospective study with a specific focus on long COVID.
Journal: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
Published: January 31, 2025
Critical Issues in the Management of CRMS/CFSPID Children: A National Real-World Survey.
Journal: Pediatric pulmonology
Published: September 12, 2024
Corrigendum to "Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 years with Cystic Fibrosis and at Least one F508dek Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor". J Pediatr. 2024 Jun 28; 274:114176.
Journal: The Journal of pediatrics
Published: August 28, 2024
Reported Adverse Events in a Multicenter Cohort of Patients Ages 6-18 Years with Cystic Fibrosis and at Least One F508del Allele Receiving Elexacaftor/Tezacaftor/Ivacaftor.
Journal: The Journal of pediatrics
Published: January 29, 2024
COVID-19 pathogenesis.
Journal: Progress in molecular biology and translational science
Published: January 18, 2024
A Peculiar Case of Pneumonia due to Mycoplasma pneumoniae in a Child with Cystic Fibrosis and Sensibilization to Aspergillus fumigatus.
Journal: Pathogens (Basel, Switzerland)
Published: November 05, 2019
Antimicrobial Treatment of Staphylococcus aureus in Patients With Cystic Fibrosis.
Journal: Frontiers in pharmacology
Published: April 08, 2019
Pediatric Tuberculosis in Italian Children: Epidemiological and Clinical Data from the Italian Register of Pediatric Tuberculosis.
Journal: International journal of molecular sciences
Published: February 22, 2016
Showing 1-8 of 8
Last Updated: 09/26/2026